<DOC>
	<DOCNO>NCT01785836</DOCNO>
	<brief_summary>This study ass safety , tolerability , efficacy dapsone subject acne vulgaris follow 12 week treatment .</brief_summary>
	<brief_title>An Extension Study Assess Safety , Tolerability , Efficacy , Treatment Adherence Dapsone Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<criteria>Participation Allergan study 225678004 Anticipates need surgery hospitalization study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>